Processa Pharmaceuticals, Inc.
Recent Filings
All 625 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 18, 2026 |
| SCHEDULE 13D/A | — | Feb 23, 2026 |
| 8-K | 8-K | Feb 19, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| 4 | FORM 4 | Feb 4, 2026 |
| 4 | FORM 4 | Feb 4, 2026 |
| 4 | FORM 4 | Feb 4, 2026 |
| 4 | FORM 4 | Feb 4, 2026 |
| 8-K | 8-K | Jan 7, 2026 |
| 8-K | 8-K | Dec 15, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Yorke Justin W | — | Purchase | 12,400 @ $0.80 | 12,400 | Jan 27, 2025 |
| Ng George K | Chief Executive Officer | Purchase | 87,200 @ $0.80 | 87,200 | Jan 27, 2025 |
| Young David | Pres. Research & Development | Purchase | 124,500 @ $0.80 | 205,405 | Jan 27, 2025 |
| Lin Patrick | Chief Business - Strategy Off | Purchase | 43,500 @ $0.80 | 43,500 | Jan 27, 2025 |
| Young David | Pres. Research & Development | Purchase | 21,000 @ $2.45 | 79,387 | Feb 7, 2024 |
| Young David | Pres. Research & Development | Purchase | 20,000 @ $2.53 | 58,387 | Feb 6, 2024 |
| Lin Patrick | Chief Business - Strategy Off | Purchase | 1,500 @ $2.40 | 27,478 | Jan 31, 2024 |
| Ng George K | Chief Executive Officer | Purchase | 10,000 @ $2.70 | 20,000 | Jan 30, 2024 |
| Yorke Justin W | — | Purchase | 8,000 @ $2.69 | 31,232 | Jan 30, 2024 |
| Yorke Justin W | — | Award / Grant | 6,000 @ $0.30 | 74,729 | Oct 12, 2023 |